Cognition Medical discusses its next generation neurovascular technologies in an interview with SmartTRA...
Despite continued weakness and share shifts in Q219, the SCS market is poised to accelerate in H219 on n...
Intraoperative neuromonitoring could be a game changer in the field of SCS by elucidating the MOA for cu...
In an interview with SmartTRAK, Robert Levy, MD, president of the International Neuromodulation Society ...
SmartTRAK highlights key takeaways from the recent North American Neuromodulation (NANS) 22nd annual mee...
The Spinal Cord Stimulation (SCS) market saw high-teens growth in FY18, but decelerated in Q418. The US ...
SmartTRAK is excited to be attending the AANS/CNS Joint Cerebrovascular Annual Meeting on Feb. 4-5, 2019...
New Products, Continued Demand Provide SCS Market Tailwinds SmartTRAK reports that with new products pro...
SmartTRAK identifies trends to watch in spinal cord stimulation With the start of a new year, it's time ...
In an interview with SmartTRAK, B. Todd Sitzman, MD, MPH, President of the North American Neuromodulatio...